Skip to main content

Share story

Capital

Optical networking startup Lumilens launches with $900M in funding

Optical networking startup Lumilens launches with $900M in funding Image: Primary
Optical networking startup Lumilens Inc. launched today with $900 million in funding. The company announced it raised $700 million in a Series C round that valued it at $5.51 billion. Atreides Management, Bain Capital Ventures, Meritech, Seligman Ventures and Spark Capital jointly led the investment. They were joined by more than a dozen others including Qualcomm Inc. Lumilens is led by co-founder and Chief Executive Officer Ankur Singla. His previous two networking startups were sold for a combined $676 million. The two-year-old company says it has already received billions of dollars worth of chip orders. Lumilens makes optical chips for scale-up and scale-out networking in artificial intelligence clusters. The chips are designed to replace copper interconnects with faster fiber-optic cabling. The company targets the scale-up market with co-packaged optics and near-packaged optics chip families. It also makes chips for scale-out networks that ship as pluggable transceivers supporting bandwidth of 800 gigabits per second or more. Lumilens says its LumiCore architecture reduces chip development time from years to months. The company will use the capital to accelerate chip development and manufacturing efforts.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from siliconangle.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...